Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Ag majors, Corteva, Syngenta, just joined the platform this last quarter and our large long-term customer Bayer in agriculture.
Allworth Financial LP lessened its stake in shares of Corteva, Inc. () by 14.6% in the 4th quarter, reports.
AlphaCrest Capital Management LLC increased its stake in Corteva by 303.8% in the 3rd quarter.
Bank of America Corp DE’s holdings in Corteva were worth $418,126,000 at the end of the most recent reporting period.
Canaccord Genuity Group initiated coverage on shares of Corteva in a report on Wednesday, June 28th.
Corteva, Inc. has a 1-year low of $43.22 and a 1-year high of $65.21.
Earlier this month, three other companies — DuPont de Nemours Inc. and spinoffs Chemours Co. and Corteva Inc. — reached a $1.18-billion deal to resolve PFAS complaints by about 300 drinking water providers.
Source: https://www.cbc.ca/news/world/3m-pfa-forever-chemicals-lawsuit-1.6886172?cmp=rss
Equities research analysts forecast that Corteva, Inc. will post 2.84 EPS for the current year.
Source: https://www.etfdailynews.com/2023/09/03/prudential-plc-sells-4718-shares-of-corteva-inc-nysectva/
Finally, Brown Brothers Harriman & Co. lifted its holdings in shares of Corteva by 0.4% in the second quarter.
Finally, Cetera Investment Advisers boosted its stake in Corteva by 4.4% during the 1st quarter.
Geneos Wealth Management Inc.’s holdings in Corteva were worth $223,000 as of its most recent SEC filing.
Great Valley Advisor Group Inc. lifted its stake in Corteva by 3.5% in the fourth quarter.
Independent Franchise Partners LLP increased its position in shares of Corteva by 38.1% during the second quarter.
Oppenheimer began coverage on shares of Corteva in a research report on Thursday, April 6th.
Royal Bank of Canada reduced their price target on shares of Corteva from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, July 13th.
Wells Fargo & Company reduced their target price on Corteva from $74.00 to $73.00 and set an “overweight” rating on the stock in a report on Monday, August 7th.